# Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy

> **NCT03866954** · PHASE2 · WITHDRAWN · sponsor: **St George's, University of London**

## Conditions studied

- Mitochondrial Diseases
- Metabolic Disease
- Inborn Errors of Metabolism

## Interventions

- **COMBINATION_PRODUCT:** EE-TP

## Key facts

- **NCT ID:** NCT03866954
- **Lead sponsor:** St George's, University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-11
- **Primary completion:** 2027-09
- **Final completion:** 2027-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change of circumstances with Commercial partner
- **Last updated:** 2023-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03866954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03866954, "Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03866954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*